En español
NIDA

NIDA Notes Articles: Cocaine

NIDA Notes Category Graphic

Animation: The Rise and Fall of the Cocaine High

November 2014
This animation shows the rapid passage of cocaine through the brain. It demonstrates that the intensity of the cocaine “high” parallels the trajectory of cocaine levels in the brain.

NIDA Notes Category Graphic

Brain Imaging Predicts Relapse to Cocaine

September 2015
A NIDA-supported study has found that a cocaine-addicted person’s chance of managing 1 whole year of abstinence correlates with activity levels in these impaired motivational and decision-making brain areas.

NIDA Notes Category Graphic

Cocaine-Induced Increase in an Immune Protein Promotes Addiction Behaviors in Mice

October 2018
Cocaine produces a portion of its rewarding effects by increasing levels of granulocyte-colony stimulating factor (G-CSF) in the brain’s reward center. Treatments that prevent G-CSF signaling in the nucleus accumbens might reduce motivation to use cocaine.

NIDA Notes Category Graphic

Digital Addiction Therapies Affirm Promise in Replication and Large Trial

November 2015
Two computerized programs improved outcomes when they were used to supplement or partially replace in-person behavioral therapy for drug addiction in recent NIDA-sponsored trials.

NIDA Notes Category Graphic

Dr. Antonello Bonci Q & A: Lighting Up the Brain To Shut Down Cocaine Seeking

July 2014
The Scientific Director of NIDA’s Intramural Research Program talks about switching off animals’ compulsive cocaine seeking by optogenetically activating the prefrontal cortex, and the implications of this work for people. In an accompanying podcast, Dr. Bonci walks viewers through experiments that showed that prefrontal cortex activity levels may constitute a simple switch controlling whether or not animals compulsively seek cocaine.

NIDA Notes Category Graphic

Dr. Thomas Kosten Q & A: Vaccines To Treat Addiction

June 2015
In this article and accompanying podcast, Dr. Thomas Kosten discusses the idea and current status of antidrug vaccines to treat substance use and addiction.

NIDA Notes Category Graphic

EEG Indicates That Cocaine Relapse Vulnerability Peaks 1 to 6 Months Into Abstinence

September 2017
Electroencephalography (EEG) may provide an objective measure of cocaine-addicted participants’ vulnerability to cue-induced relapse. The assessment of cue-induced responsiveness may be useful in the clinical setting for assessing relapse risk and tailoring interventions to maintain abstinence among cocaine-addicted adults. 

NIDA Notes Category Graphic

Endocannabinoid Regulates Cocaine Reward

March 2017
Investigators have shown that 2-AG, an endocannabinoid (i.e., a cannabinoid manufactured within the body, as opposed to plant-derived), augments the cocaine-induced dopamine surge in the brain’s reward system. The discovery adds to evidence that inhibiting activity in the endocannabinoid system might reduce cocaine’s rewarding and addictive effects.  

NIDA Notes Category Graphic

Gene Transfer Therapy for Cocaine Addiction Passes Tests in Animals

January 2016
Giving mice a modified version of a naturally occurring gene blocks cocaine’s stimulant effects without affecting the animals’ physiological or metabolic health. The new evidence advances the proposed therapy a step closer to readiness for testing in people.

NIDA Notes Category Graphic

Gene Variants Reduce Opioid Risks

June 2014
Two recent studies suggest that genotyping may enable clinicians to base therapies on individual patients’ potential responsiveness to opioid drugs’ therapeutic effects and vulnerability to their harmful effects.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics